US Stock MarketDetailed Quotes
OCUL Ocular Therapeutix
- 10.390
- -0.140-1.33%
Close Nov 1 16:00 ET
- 10.390
- 0.0000.00%
Post 20:01 ET
1.62BMarket Cap-9532P/E (TTM)
10.750High10.330Low822.02KVolume10.530Open10.530Pre Close8.61MTurnover0.69%Turnover RatioLossP/E (Static)155.92MShares11.77552wk High4.29P/B1.24BFloat Cap1.99552wk Low--Dividend TTM118.91MShs Float44.190Historical High--Div YieldTTM3.99%Amplitude1.995Historical Low10.468Avg Price1Lot Size
Ocular Therapeutix Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 8.26%16.44M | 10.47%14.77M | 13.49%58.44M | 5.16%14.8M | 26.04%15.08M | 23.81%15.19M | 1.42%13.37M | 18.32%51.49M | 14.36%14.08M | -1.55%11.97M |
| Operating revenue | 8.26%16.44M | 10.47%14.77M | 13.49%58.44M | 5.16%14.8M | 26.04%15.08M | 23.81%15.19M | 1.42%13.37M | 18.32%51.49M | 14.36%14.08M | -1.55%11.97M |
| Cost of revenue | 15.72%1.51M | 9.23%1.33M | 16.32%5.28M | 36.96%1.39M | 28.33%1.38M | 12.90%1.3M | -6.62%1.21M | 3.04%4.54M | -8.66%1.01M | -18.09%1.07M |
| Gross profit | 7.56%14.93M | 10.59%13.45M | 13.22%53.16M | 2.69%13.42M | 25.82%13.7M | 24.94%13.88M | 2.30%12.16M | 20.04%46.95M | 16.63%13.06M | 0.45%10.89M |
| Operating expense | 69.87%58.52M | 29.84%45.07M | 7.91%135.54M | 3.21%33.47M | 1.49%32.92M | 11.04%34.45M | 16.79%34.71M | 7.22%125.61M | 10.86%32.42M | 6.80%32.44M |
| Selling and administrative expenses | 53.24%29.67M | 21.88%24.33M | 3.25%74.49M | -8.53%17.27M | -4.37%17.9M | 7.98%19.36M | 20.11%19.96M | 7.57%72.15M | 13.26%18.88M | 6.03%18.72M |
| -Selling and marketing expense | -13.65%1.28M | 5.94%1.27M | 15.89%4.83M | -4.96%-26.48M | -8.55%9.32M | -85.40%1.48M | -86.80%1.2M | -88.16%4.17M | -376.09%-25.22M | 6.37%10.19M |
| -General and administrative expense | 58.78%28.39M | 22.90%23.06M | 2.47%69.66M | -0.81%43.75M | 0.62%8.58M | 129.59%17.88M | 148.33%18.77M | 113.24%67.98M | 485.34%44.11M | 5.62%8.53M |
| Research and development costs | 91.18%28.86M | 40.60%20.74M | 14.20%61.06M | 19.58%16.2M | 9.48%15.02M | 15.22%15.09M | 12.57%14.75M | 6.75%53.46M | 7.67%13.54M | 7.86%13.72M |
| Operating profit | -111.91%-43.59M | -40.21%-31.62M | -4.74%-82.38M | -3.56%-20.05M | 10.82%-19.21M | -3.28%-20.57M | -26.45%-22.55M | -0.79%-78.65M | -7.27%-19.36M | -10.32%-21.54M |
| Net non-operating interest income expense | 328.48%2.84M | 89.29%-129K | -18.17%-7.36M | -89.04%-2.69M | -46.43%-2.21M | 23.41%-1.24M | 27.63%-1.21M | 6.24%-6.22M | 14.93%-1.42M | 8.42%-1.51M |
| Non-operating interest income | 706.95%6.04M | 596.63%3.92M | 399.12%3.98M | 244.92%1.46M | 325.26%1.21M | 924.66%748K | 3,027.78%563K | 2,318.18%798K | 6,950.00%423K | 3,971.43%285K |
| Non-operating interest expense | 60.52%3.2M | 129.13%4.05M | 61.46%11.34M | 124.74%4.15M | 90.65%3.43M | 17.39%1.99M | 5.05%1.77M | 5.26%7.02M | 9.94%1.85M | 8.38%1.8M |
| Other net income (expense) | -367.64%-3.03M | -404.30%-33.1M | -34.96%9M | -223.56%-6.48M | 1,947.35%20.91M | -59.21%1.13M | -194.36%-6.56M | -82.28%13.84M | -66.97%5.24M | -104.75%-1.13M |
| Gain on sale of security | -367.64%-3.03M | 21.50%-5.15M | -137.48%-5.19M | -223.56%-6.48M | 693.29%6.72M | -59.21%1.13M | -194.32%-6.56M | -82.28%13.84M | -66.97%5.24M | -104.75%-1.13M |
| Special income (charges) | --0 | ---27.95M | --14.19M | --0 | --14.19M | --0 | --0 | --0 | --0 | --0 |
| -Less:Other special charges | ---- | --27.95M | ---14.19M | --0 | ---14.19M | ---- | ---- | ---- | ---- | ---- |
| Other non- operating income (expenses) | ---- | ---- | 0.00%-1K | --0 | ---- | ---- | 50.00%-1K | -200.00%-1K | --0 | --1K |
| Income before tax | -111.67%-43.78M | -113.89%-64.85M | -13.65%-80.74M | -88.01%-29.22M | 97.87%-516K | -10.21%-20.68M | -141.73%-30.32M | -984.05%-71.04M | -303.69%-15.54M | -1,010.35%-24.19M |
| Income tax | ||||||||||
| Net income | -111.67%-43.78M | -113.89%-64.85M | -13.65%-80.74M | -88.01%-29.22M | 97.87%-516K | -10.21%-20.68M | -141.73%-30.32M | -984.05%-71.04M | -303.69%-15.54M | -1,010.35%-24.19M |
| Net income continuous Operations | -111.67%-43.78M | -113.89%-64.85M | -13.65%-80.74M | -88.01%-29.22M | 97.87%-516K | -10.21%-20.68M | -141.73%-30.32M | -984.05%-71.04M | -303.69%-15.54M | -1,010.35%-24.19M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -111.67%-43.78M | -113.89%-64.85M | -13.65%-80.74M | -88.01%-29.22M | 97.87%-516K | -10.21%-20.68M | -141.73%-30.32M | -984.05%-71.04M | -303.69%-15.54M | -1,010.35%-24.19M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -111.67%-43.78M | -113.89%-64.85M | -13.65%-80.74M | -88.01%-29.22M | 97.87%-516K | -10.21%-20.68M | -141.73%-30.32M | -984.05%-71.04M | -303.69%-15.54M | -1,010.35%-24.19M |
| Basic earnings per share | 0.00%-0.26 | -25.64%-0.49 | -9.78%-1.01 | -75.00%-0.35 | 96.77%-0.01 | -8.33%-0.26 | -143.75%-0.39 | -922.22%-0.92 | -300.00%-0.2 | -1,133.33%-0.31 |
| Diluted earnings per share | 0.00%-0.26 | -25.64%-0.49 | -5.15%-1.02 | -45.83%-0.35 | 19.35%-0.25 | -4.00%-0.26 | -77.27%-0.39 | 1.02%-0.97 | -4.35%-0.24 | -34.78%-0.31 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data